Antibodies against recoverin have been detected in the serum of patients with cancer-associated retinopathy and are thought to penetrate the blood–retinal barrier and inhibit recoverin activity in the visual transduction cascade, causing photoreceptor degeneration [19,20,21]. Here, RCVRN is linked to cancer.